IMAX extends CEO Gelfond's contract to Dec 2028 with increased equity awards

IMAX CORP

Term extended to December 31, 2028; base salary remains $1.2 million annually.
Target annual bonus of 100% of base salary, capped at 200%; unchanged from prior.
Annual RSU grant of $3.5M vesting over 3 years, plus PSU grant of $3.5M tied to EBITDA and TSR.
PSU payout ranges 0%-200%; 60% based on EBITDA, 40% on relative total shareholder return.
Severance terms updated: equity continues vesting on termination without cause or for good reason through 2028.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.